Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Fumitake Kai"'
Autor:
Pankaj Taneja, Dejan Maglic, Fumitake Kai, Sinan Zhu, Robert D. Kendig, A. Fry Elizabeth, Kazushi Inoue
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 4 (2010)
The use of biomarkers ensures breast cancer patients receive optimal treatment. Established biomarkers such as estrogen receptor (ER) and progesterone receptor (PR) have been playing significant roles in the selection and management of patients for e
Externí odkaz:
https://doaj.org/article/f53e491ca7b3469cbefd63607af0f3a8
Autor:
Kazushi Inoue, Guangchao Sui, Sarah J. Lagedrost, Elizabeth A. Fry, Rachel L. Morgan, Takayuki Sugiyama, Dejan Maglic, Fumitake Kai, Robert D. Kendig, Donna P. Frazier
PDF file - 786K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4cebbb2484bbfe6012b87aed732b80
https://doi.org/10.1158/0008-5472.22394465
https://doi.org/10.1158/0008-5472.22394465
Autor:
Kazushi Inoue, Guangchao Sui, Sarah J. Lagedrost, Elizabeth A. Fry, Rachel L. Morgan, Takayuki Sugiyama, Dejan Maglic, Fumitake Kai, Robert D. Kendig, Donna P. Frazier
PDF file - 49K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46a4a6d5a0b7ef7a80ddcf4f029c99bb
https://doi.org/10.1158/0008-5472.22394462
https://doi.org/10.1158/0008-5472.22394462
Autor:
Kazushi Inoue, Mark C. Willingham, Donna P. Frazier, Robert D. Kendig, Takayuki Sugiyama, Fumitake Kai, Dejan Maglic, Pankaj Taneja
Supplementary Methods, Figures 1-6 from Critical Roles of DMP1 in Human Epidermal Growth Factor Receptor 2/neu-Arf-p53 Signaling and Breast Cancer Development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d205e41e81bbb4292952d713051615d
https://doi.org/10.1158/0008-5472.22384388
https://doi.org/10.1158/0008-5472.22384388
Autor:
Kazushi Inoue, Mark C. Willingham, Donna P. Frazier, Robert D. Kendig, Takayuki Sugiyama, Fumitake Kai, Dejan Maglic, Pankaj Taneja
Human epidermal growth factor receptor 2 (HER2) overexpression stimulates cell growth in p53-mutated cells while it inhibits cell proliferation in those with wild-type p53, but the molecular mechanism is unknown. The Dmp1 promoter was activated by HE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a0ca2c282343deb31ba6f72d484afa
https://doi.org/10.1158/0008-5472.c.6500870.v1
https://doi.org/10.1158/0008-5472.c.6500870.v1
Autor:
Kazushi Inoue, Guangchao Sui, Sarah J. Lagedrost, Elizabeth A. Fry, Rachel L. Morgan, Takayuki Sugiyama, Dejan Maglic, Fumitake Kai, Robert D. Kendig, Donna P. Frazier
The transcription factor Dmp1 is a Ras/HER2-activated haplo-insufficient tumor suppressor that activates the Arf/p53 pathway of cell-cycle arrest. Recent evidence suggests that Dmp1 may activate p53 independently of Arf in certain cell types. Here, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74811d246a423a731bebe2eacb4c0214
https://doi.org/10.1158/0008-5472.c.6504035.v1
https://doi.org/10.1158/0008-5472.c.6504035.v1
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 21
International Journal of Molecular Sciences, Vol 21, Iss 7971, p 7971 (2020)
Volume 21
Issue 21
International Journal of Molecular Sciences, Vol 21, Iss 7971, p 7971 (2020)
Lung cancer is the leading cause of cancer deaths in the world, and accounts for more solid tumor deaths than any other carcinomas. The prognostic values of DMP1, ARF, and p53-loss are unknown in lung cancer. We have conducted survival analyses of no
Autor:
Hideyasu Matsuyama, Hiroshi Furuse, Mamoru Narukawa, Munehisa Ueno, Keiji Inoue, Taro Shuin, Hideo Fukuhara, Kiyohide Fujimoto, Yoshihiko Hirao, Fumitake Kai, Seiichiro Ozono, Takahiko Hara, Satoshi Anai, Masafumi Oyama
Publikováno v:
Photodiagnosis and Photodynamic Therapy. 12:193-200
Background Photodynamic diagnosis (PDD) of non-muscle-invasive bladder cancer (NMIBC) following transurethral administration of a hexalated form of 5-aminolevulinic acid (5-ALA), 5-ALA hexyl ester, is widely performed in Western countries. In this st
Publikováno v:
Japanese Journal of Clinical Oncology. 43:747-751
We present two patients with a long-term response to axitinib for cytokine-refractory metastatic renal cell carcinoma. One patient has had a continuing partial response for 58 months with cytokine-intolerant metastatic renal cell carcinoma and the ot
Autor:
Seiichiro Ozono, Soichi Mugiya, Yasuo Ishii, Taiki Kato, Fumitake Kai, Takahisa Suzuki, Hiroshi Furuse, Tatsuya Takayama, Masao Nagata, Takayuki Sugiyama, Atsushi Otsuka, Keita Tamura
Publikováno v:
The Japanese Journal of Urology. 104:17-21
A 58-year-old man presented with nausea and left flank pain. The patient was referred to our hospital based on clear detection of anemia and computed tomography findings of bilateral adrenal tumors with hemorrhage and a mass in the apex of the left l